Connor, Clark & Lunn Investment Management Ltd. Tandem Diabetes Care Inc Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 784,218 shares of TNDM stock, worth $12.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
784,218
Previous 644,988
21.59%
Holding current value
$12.2 Million
Previous $12.4 Million
18.29%
% of portfolio
0.06%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding TNDM
# of Institutions
301Shares Held
81.6MCall Options Held
2.87MPut Options Held
134K-
Black Rock Inc. New York, NY11.1MShares$173 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.37MShares$115 Million0.0% of portfolio
-
Sessa Capital Im, L.P. New York, NY5MShares$77.7 Million2.82% of portfolio
-
Gw&K Investment Management, LLC Boston, MA2.89MShares$44.9 Million0.48% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.7MShares$42 Million1.02% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $998M
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...